HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allan S Jaffe Selected Research

Transplantation

4/2016Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure.
3/2013Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure.
1/2009Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.
7/2007Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Allan S Jaffe Research Topics

Disease

90Myocardial Infarction
08/2022 - 07/2004
55Heart Failure
07/2022 - 01/2003
39Acute Coronary Syndrome
08/2022 - 07/2004
30Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 07/2005
19ST Elevation Myocardial Infarction
12/2020 - 11/2006
18Chest Pain (Chest Pains)
08/2022 - 11/2005
13Coronary Artery Disease (Coronary Atherosclerosis)
04/2019 - 09/2007
10Infarction (Infarctions)
01/2022 - 10/2004
10Thrombosis (Thrombus)
10/2021 - 05/2009
9Necrosis
12/2018 - 06/2004
8Ischemia
01/2022 - 06/2004
8Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 01/2002
8Critical Illness (Critically Ill)
01/2021 - 09/2002
7Heart Arrest (Cardiac Arrest)
01/2021 - 08/2007
6Unstable Angina
08/2022 - 10/2002
6Coronary Disease (Coronary Heart Disease)
01/2019 - 07/2004
6Pain (Aches)
02/2012 - 08/2006
5Stroke (Strokes)
07/2022 - 01/2016
5Heart Diseases (Heart Disease)
10/2021 - 07/2006
5Cardiogenic Shock
12/2020 - 01/2019
5Fibrosis (Cirrhosis)
11/2020 - 12/2015
5Septic Shock (Toxic Shock Syndrome)
02/2020 - 12/2013
5Sepsis (Septicemia)
02/2020 - 12/2013
5Hemorrhage
12/2019 - 01/2009
4Atrial Fibrillation
12/2022 - 05/2009
4COVID-19
05/2021 - 09/2020
4Hypertension (High Blood Pressure)
01/2019 - 09/2008
4Non-ST Elevated Myocardial Infarction
10/2017 - 05/2005
3Cardiotoxicity
04/2019 - 10/2002
3Amyloidosis
01/2019 - 01/2002
3Death (Near-Death Experience)
04/2016 - 07/2007
3Chronic Kidney Failure (Chronic Renal Failure)
11/2015 - 10/2002
3Myocarditis (Carditis)
01/2015 - 09/2008
3Immunoglobulin Light-chain Amyloidosis
09/2004 - 05/2003
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2022 - 12/2020
2Hemolysis
11/2021 - 01/2019
2Pulmonary Embolism
10/2021 - 02/2017
2Wounds and Injuries (Trauma)
10/2021 - 12/2018
2Respiratory Insufficiency (Respiratory Failure)
01/2021 - 08/2019
2Obesity
12/2020 - 06/2006
2Dyslipidemias (Dyslipidemia)
12/2020 - 01/2018
2Atherosclerosis
12/2020 - 09/2008
2Aortic Valve Stenosis (Aortic Stenosis)
01/2020 - 05/2014
2Acute Kidney Injury (Acute Renal Failure)
01/2019 - 08/2018
2Inflammation (Inflammations)
01/2018 - 09/2010
2Cardiac Arrhythmias (Arrythmia)
01/2018 - 09/2017
2Breast Neoplasms (Breast Cancer)
03/2008 - 09/2004
2Neoplasms (Cancer)
03/2008 - 09/2004
2Pulmonary Edema
03/2008 - 07/2006
2Renal Insufficiency (Renal Failure)
12/2007 - 10/2002
1Reinjuries
01/2022

Drug/Important Bio-Agent (IBA)

89TroponinIBA
12/2022 - 05/2003
65Biomarkers (Surrogate Marker)IBA
08/2022 - 07/2004
40Troponin T (Troponin T1)IBA
12/2022 - 06/2004
28Brain Natriuretic Peptide (Natrecor)FDA Link
10/2021 - 09/2004
28Troponin IIBA
01/2019 - 01/2002
22trans-crotonin (CTN)IBA
08/2022 - 04/2008
15pro-brain natriuretic peptide (1-76)IBA
10/2021 - 11/2007
15Natriuretic PeptidesIBA
05/2021 - 09/2005
9omega-Chloroacetophenone (Mace)IBA
07/2022 - 07/2008
7Creatine Kinase (Creatine Phosphokinase)IBA
02/2010 - 10/2002
6oxidized low density lipoproteinIBA
01/2022 - 01/2016
51-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
04/2017 - 01/2006
4LDL CholesterolIBA
01/2022 - 01/2016
4Pharmaceutical PreparationsIBA
06/2017 - 08/2010
4CytokinesIBA
07/2015 - 05/2005
3CeramidesIBA
01/2022 - 01/2018
3Oxygen (Dioxygen)IBA
11/2020 - 02/2014
3Galectin 3 (LGALS3)IBA
01/2019 - 12/2015
3Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA
02/2014 - 07/2009
3EnzymesIBA
12/2012 - 07/2006
3CreatinineIBA
06/2010 - 10/2002
2Lipoprotein(a)IBA
01/2022 - 12/2020
2Biotin (Vitamin H)FDA Link
11/2021 - 01/2019
2Triglycerides (Triacylglycerol)IBA
01/2020 - 01/2018
2sacubitril and valsartan sodium hydrate drug combinationIBA
01/2019 - 06/2017
2DobutamineFDA LinkGeneric
01/2019 - 09/2005
2Apolipoproteins B (ApoB)IBA
07/2017 - 01/2016
2bivalirudin (Angiomax)FDA Link
12/2016 - 09/2016
2Arginine Vasopressin (Argipressin)IBA
07/2014 - 03/2013
2Peptides (Polypeptides)IBA
03/2013 - 08/2009
2Caspase 3 (Caspase-3)IBA
07/2011 - 01/2011
2C-Reactive ProteinIBA
04/2010 - 03/2007
2Interleukin-6 (Interleukin 6)IBA
03/2010 - 12/2007
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2008 - 09/2004
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2008 - 09/2004
2Antidepressive Agents (Antidepressants)IBA
07/2005 - 10/2002
1CholesterolIBA
01/2022

Therapy/Procedure

19Percutaneous Coronary Intervention
01/2021 - 06/2006
17Therapeutics
01/2017 - 10/2002
4Secondary Prevention
04/2019 - 01/2014
4Transplantation
04/2016 - 07/2007
3Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022 - 10/2008
3Artificial Respiration (Mechanical Ventilation)
01/2021 - 01/2019
2Thrombolytic Therapy
12/2020 - 12/2012
2Extracorporeal Membrane Oxygenation
03/2020 - 12/2019
2Catheters
01/2020 - 07/2012
2Drug Therapy (Chemotherapy)
04/2019 - 01/2012
2Length of Stay
01/2018 - 07/2012
2Stents
09/2016 - 02/2015